Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Strategy Sells 2.09M MSTR Shares, Buys 485 BTC in Nov. 9-15 Week

Strategy Inc filed a Form 8-K on November 16, 2026, disclosing its at-the-market offering activity, bitcoin purchases, share repurchase program updates, and cash dividend declarations for the period ending November 15, 2026.

Nitish Kishor | 16 November 2026

Relmada Names Jakobsen Chief Development Officer

Relmada Therapeutics, Inc. filed a current report on November 16, 2026, announcing the appointment of Jørn Skibsted Jakobsen, MD, PhD, as its Chief Development Officer.

Aakashdeep | 16 November 2026

Optimum Communications Skips $102.5M Interest Payment

Optimum Communications, Inc. filed a Form 8-K on November 16, 2026, disclosing that its wholly owned subsidiary CSC Holdings LLC elected not to make approximately $102.5 million in interest payments due that same day, entering a 30-day grace period under the applicable indentures.

Aditi Sarkar | 16 November 2026

Joseph E. Creed Joins Walmart Board, Nov. 13, 2026

Walmart Inc. filed a Form 8-K on November 16, 2026, disclosing the appointment of Joseph E. Creed to its Board of Directors, effective November 13, 2026, along with his committee assignments and prorated director compensation details.

Manish Choudhary | 16 November 2026

Digimarc Adds Three Directors in Ocho Investments Deal

Digimarc Corporation filed an 8-K on November 16, 2026, disclosing a Cooperation Agreement dated November 15, 2026, with Ocho Investments LLC, under which the Board was expanded and three new directors were appointed while four existing directors submitted resignations effective December 31, 2026.

Nitish Kishor | 16 November 2026

Pasithea PAS-004 Phase 1 Data Shared, FDA Clears Phase 2 IND

Pasithea Therapeutics Corp. filed a current report on Form 8-K on November 16, 2026, disclosing that on November 13, 2026, the company announced initial clinical data from its ongoing Phase 1/1b study of PAS-004 and received FDA clearance of an Investigational New Drug application …

Shwetambri Chauhan | 16 November 2026

Super League Enterprise Buys 8 Bitcoin at ~$68,948.90 Each

Super League Enterprise, Inc. filed a current report on November 16, 2026, disclosing that on November 13, 2026, the company purchased eight Bitcoin as part of its exploration of Bitcoin as a treasury asset.

Manish Choudhary | 16 November 2026

Enlivex $7.5M Registered Direct Offering, November 2026

Enlivex Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 16, 2026, disclosing a securities purchase agreement for a registered direct offering of up to $7,500,000 in ordinary shares and accompanying warrants.

Manish Choudhary | 16 November 2026

LanzaTech Reports Q3 2026 with 13,089,197 Shares Outstanding

LanzaTech Global, Inc. filed a quarterly report on Form 10-Q with the SEC covering the period ended September 30, 2026, disclosing consolidated balance sheet data, share counts, and ongoing business developments including activities related to its gas fermentation and carbon capture technology operations.

Shwetambri Chauhan | 16 November 2026

Ticketplus Launches Platform in Bolivia as 13th Active Market

Ticketplus Ltd. filed a Form 6-K with the SEC on November 16, 2026, announcing the official launch of its ticketing platform in Bolivia, which the company described as its 13th active market.

Vinay Lochav | 16 November 2026
Support

Hi! How can we help you today?

Loading…